TABLE 2.
Tumor types in the cohort.
| Tumor type | #Patient |
|---|---|
| Adrenocortical carcinoma | 1 (0.04%) |
| AOV cancer (Ampulla of Vater) | 24 (1.07%) |
| Bladder cancer | 73 (3.26%) |
| Brain tumor | 1 (0.04%) |
| Breast cancer | 29 (1.30%) |
| CCC (Cholangiocellular carcinoma) | 157 (7.01%) |
| Cervical cancer | 1 (0.04%) |
| Colorectal cancer | 702 (31.35%) |
| Duodenal cancer | 6 (0.27%) |
| EAC cancer (Esophageal adenocarcinoma) | 1 (0.04%) |
| Esophageal cancer | 1 (0.04%) |
| Fallopian tube cancer | 1 (0.04%) |
| Gallbladder cancer | 49 (2.19%) |
| Gastric cancer | 481 (21.48%) |
| GIST (Gastrointestinal stromal tumor) | 17 (0.76%) |
| HCC (Hepatocellular carcinoma) | 46 (2.05%) |
| Head and Neck cancer | 18 (0.80%) |
| Kidney cancer | 9 (0.40%) |
| Malignant solitary fibrous tumor | 5 (0.22%) |
| Malignant thymoma | 1 (0.04%) |
| Melanoma | 111 (4.96%) |
| Merkel cell carcinoma | 1 (0.04%) |
| MUO (Metastasis of unknown origin) | 25 (1.12%) |
| NET (Neuroendocrine tumors) | 24 (1.07%) |
| Neurofibromatosis | 1 (0.04%) |
| NSCLC (Non-small cell lung cancer) | 119 (5.31%) |
| Ovarian cancer | 9 (0.40%) |
| Paget’s disease | 2 (0.09%) |
| Pancreatic cancer | 123 (5.49%) |
| Prostate cancer | 5 (0.22%) |
| Sarcoma | 180 (8.04%) |
| SCLC (Small cell lung cancer) | 1 (0.04%) |
| Skin cancer | 4 (0.18%) |
| Small bowel cancer | 4 (0.18%) |
| Thymic carcinoma | 2 (0.09%) |
| Thyroid cancer | 3 (0.13%) |
| Tracheobronchial adenoid cystic carcinoma | 1 (0.04%) |
| Uterine cancer | 1 (0.04%) |
| 2,239 |